Katherine J Bangen1,2, Kelsey R Thomas1,2, Danielle L Sanchez3, Emily C Edmonds1,2, Alexandra J Weigand4, Lisa Delano-Wood2,5, Mark W Bondi2,5. 1. Research Service, VA San Diego Healthcare System, San Diego, CA, USA. 2. Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA. 3. Department of Psychology, San Diego State University, San Diego, CA, USA. 4. San Diego Joint Doctoral Program in Clinical Psychology, San Diego State University/University of California, San Diego, CA, USA. 5. Psychology Service, VA San Diego Healthcare System, San Diego, CA, USA.
Abstract
BACKGROUND: Altered cerebral blood flow (CBF) has been linked to increased risk for Alzheimer's disease (AD). However, whether altered CBF contributes to AD risk by accelerating cognitive decline remains unclear. It also remains unclear whether reductions in CBF accelerate neurodegeneration and development of small vessel cerebrovascular disease. OBJECTIVE: To examine associations between CBF and trajectories of memory performance, regional brain atrophy, and global white matter hyperintensity (WMH) volume. METHOD: 147 Alzheimer's Disease Neuroimaging Initiative participants free of dementia underwent arterial spin labeling (ASL) magnetic resonance imaging (MRI) to measure CBF and serial neuropsychological and structural MRI examinations. Linear mixed effects models examined 5-year rate of change in memory and 4-year rate of change in regional brain atrophy and global WMH volumes as a function of baseline regional CBF. Entorhinal and hippocampal CBF were examined in separate models. RESULTS: Adjusting for demographic characteristics, pulse pressure, apolipoprotein E ɛ4 positivity, cerebrospinal fluid p-tau/Aβ ratio, and neuronal metabolism (i.e., fluorodeoxyglucose standardized uptake value ratio), lower baseline entorhinal CBF predicted faster rates of decline in memory as well as faster entorhinal thinning and WMH progression. Hippocampal CBF did not predict cognitive or brain structure trajectories. CONCLUSION: Findings highlight the importance of early cerebrovascular dysfunction in AD risk and suggest that entorhinal CBF as measured by noninvasive ASL MRI is a useful biomarker predictive of future cognitive decline and of risk of both.
BACKGROUND: Altered cerebral blood flow (CBF) has been linked to increased risk for Alzheimer's disease (AD). However, whether altered CBF contributes to AD risk by accelerating cognitive decline remains unclear. It also remains unclear whether reductions in CBF accelerate neurodegeneration and development of small vessel cerebrovascular disease. OBJECTIVE: To examine associations between CBF and trajectories of memory performance, regional brain atrophy, and global white matter hyperintensity (WMH) volume. METHOD: 147 Alzheimer's Disease Neuroimaging Initiative participants free of dementia underwent arterial spin labeling (ASL) magnetic resonance imaging (MRI) to measure CBF and serial neuropsychological and structural MRI examinations. Linear mixed effects models examined 5-year rate of change in memory and 4-year rate of change in regional brain atrophy and global WMH volumes as a function of baseline regional CBF. Entorhinal and hippocampal CBF were examined in separate models. RESULTS: Adjusting for demographic characteristics, pulse pressure, apolipoprotein E ɛ4 positivity, cerebrospinal fluid p-tau/Aβ ratio, and neuronal metabolism (i.e., fluorodeoxyglucose standardized uptake value ratio), lower baseline entorhinal CBF predicted faster rates of decline in memory as well as faster entorhinal thinning and WMH progression. Hippocampal CBF did not predict cognitive or brain structure trajectories. CONCLUSION: Findings highlight the importance of early cerebrovascular dysfunction in AD risk and suggest that entorhinal CBF as measured by noninvasive ASL MRI is a useful biomarker predictive of future cognitive decline and of risk of both.
Entities:
Keywords:
Aging; Alzheimer’s disease; cognition; entorhinal cortex regional blood flow; magnetic resonance imaging; neuropsychology; perfusion; white matter hyperintensities
Authors: William J Jagust; Dan Bandy; Kewei Chen; Norman L Foster; Susan M Landau; Chester A Mathis; Julie C Price; Eric M Reiman; Daniel Skovronsky; Robert A Koeppe Journal: Alzheimers Dement Date: 2010-05 Impact factor: 21.566
Authors: Ozioma C Okonkwo; Guofan Xu; Jennifer M Oh; N Maritza Dowling; Cynthia M Carlsson; Catherine L Gallagher; Alex C Birdsill; Matthew Palotti; Whitney Wharton; Bruce P Hermann; Asenath LaRue; Barbara B Bendlin; Howard A Rowley; Sanjay Asthana; Mark A Sager; Sterling C Johnson Journal: Cereb Cortex Date: 2012-12-12 Impact factor: 5.357
Authors: A T Du; G H Jahng; S Hayasaka; J H Kramer; H J Rosen; M L Gorno-Tempini; K P Rankin; B L Miller; M W Weiner; N Schuff Journal: Neurology Date: 2006-10-10 Impact factor: 9.910
Authors: Rahul S Desikan; Mert R Sabuncu; Nicholas J Schmansky; Martin Reuter; Howard J Cabral; Christopher P Hess; Michael W Weiner; Alessandro Biffi; Christopher D Anderson; Jonathan Rosand; David H Salat; Thomas L Kemper; Anders M Dale; Reisa A Sperling; Bruce Fischl Journal: PLoS One Date: 2010-09-23 Impact factor: 3.240
Authors: Amy J Jak; Mark W Bondi; Lisa Delano-Wood; Christina Wierenga; Jody Corey-Bloom; David P Salmon; Dean C Delis Journal: Am J Geriatr Psychiatry Date: 2009-05 Impact factor: 4.105
Authors: Isabel J Sible; Belinda Yew; Shubir Dutt; Yanrong Li; Anna E Blanken; Jung Yun Jang; Jean K Ho; Anisa J Marshall; Arunima Kapoor; Aimée Gaubert; Katherine J Bangen; Virginia E Sturm; Xingfeng Shao; Danny J Wang; Daniel A Nation Journal: Neuroimage Rep Date: 2022-01-18